Alnylam Pharmaceuticals (NASDAQ:ALNY) Releases Quarterly Earnings Results, Beats Expectations By $0.23 EPS

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) posted its earnings results on Thursday. The biopharmaceutical company reported ($0.52) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.75) by $0.23, Briefing.com reports. The firm had revenue of $494.33 million for the quarter, compared to analyst estimates of $428.01 million. During the same […]

Related Keywords

William Blair ,Cantor Fitzgerald ,News Ratings For Alnylam Pharmaceuticals Daily ,Alnylam Pharmaceuticals Company Profile ,Earnings History For Alnylam Pharmaceuticals ,Jpmorgan Chase Co ,Alnylam Pharmaceuticals Inc ,Alnylam Pharmaceuticals ,Alnylam Pharmaceuticals Stock ,Goldman Sachs Group ,Get Free Report ,Alnylam Pharmaceuticals Daily ,Nasdaq Alny ,Dalny ,Medical ,02043q10 ,Earnings ,